PUBLICATION

Extracellular vesicles rich in HAX1 promote angiogenesis by modulating ITGB6 translation

Authors
You, B., Pan, S., Gu, M., Zhang, K., Xia, T., Zhang, S., Chen, W., Xie, H., Fan, Y., Yao, H., Cheng, T., Zhang, P., Liu, D., You, Y.
ID
ZDB-PUB-241031-12
Date
2022
Source
Journal of extracellular vesicles   11: e12221e12221 (Journal)
Registered Authors
Liu, Dong
Keywords
FAK pathway, HAX1, ITGB6, angiogenesis, extracellular vesicles, nasopharyngeal carcinoma, translation
MeSH Terms
  • Extracellular Vesicles*/genetics
  • Neovascularization, Pathologic/genetics
  • Nasopharyngeal Neoplasms*/metabolism
  • Endothelial Cells/metabolism
  • Humans
  • Adaptor Proteins, Signal Transducing*/metabolism
  • Nasopharyngeal Carcinoma/genetics
PubMed
35524442 Full text @ J Extracell Vesicles
Abstract
Tumour-associated angiogenesis plays a critical role in metastasis, the main cause of malignancy-related death. Extracellular vesicles (EVs) can regulate angiogenesis to participate in tumour metastasis. Our previous study showed that EVs rich in HAX1 are associated with in metastasis of nasopharyngeal carcinoma (NPC). However, the mechanism by which HAX1 of EVs promotes metastasis and angiogenesis is unclear. In this study, we demonstrated that EVs rich in HAX1 promote angiogenesis phenotype by activating the FAK pathway in endothelial cells (ECs) by increasing expression level of ITGB6. The expression level of HAX1 is markedly correlated with microvessel density (MVDs) in NPC and head and neck cancers based on an analysis of IHC. In addition to a series of in vitro cellular analyses, in vivo models revealed that HAX1 was correlated with migration and blood vessel formation of ECs, and metastasis of NPC. Using ribosome profiling, we found that HAX1 regulates the FAK pathway to influence microvessel formation and promote NPC metastasis by enhancing the translation efficiency of ITGB6. Our findings demonstrate that HAX1 can be used as an important biomarker for NPC metastasis, providing a novel basis for antiangiogenesis therapy in clinical settings.
Genes / Markers
Figures
Show all Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping